In Silico and In Vitro Screening of Some Pregnane Glycosides Isolated from Certain Caralluma Species as SARS‐COV‐2 Main Protease Inhibitors
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202301786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Essam Abdel-Sattar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, 11562, Cairo, Egypt. Hauptthemen laut MEDLINE: Apocynaceae, Coronavirus 3C Proteases, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
SARS‐CoV‐2 caused pandemic represented a major risk for the worldwide human health, animal health and economy, forcing extraordinary efforts to discover drugs for its prevention and cure. Considering the extensive interest in the pregnane glycosides because of their diverse structures and excellent biological activities, we investigated them as antiviral agents against SARS‐COV‐2. We selected 21 pregnane glycosides previously isolated from the genus Caralluma from Asclepiadaceae family to be tested through virtual screening molecular docking simulations for their potential inhibition of SARS‐CoV‐2 M pro . Almost all target compounds showed a more or equally negative docking energy score relative to the co‐crystallized inhibitor X77 (S=−12.53 kcal/mol) with docking score range of (−12.55 to −19.76 kcal/mol) and so with a potent predicted binding affinity to the target enzyme. The activity of the most promising candidates was validated by in vitro testing. Arabincoside C showed the highest activity (IC 50 =35.42 μg/ml) and the highest selectivity index (SI=9.9) followed by Russelioside B (IC 50 =50.80 μg/ml), and Arabincoside B (IC 50 =53.31 μg/ml).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, 11562, Cairo, Egypt.
- Center of Scientific Excellence for Influenza Viruses, National Research Centre, 12622, Giza, Egypt.
- Department of microbiology, Faculty of pharmacy, Ahram Canadian University, 6 th of October, Giza, 12566, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, 11562, Cairo, Egypt.
- Medicinal Chemistry Department, Faculty of Pharmacy, King Salman International University (KSIU), 46612, South Sinai, Egypt.
- School of Pharmacy, College of Health and Science, University of Lincoln, Joseph Banks Laboratories, Green Lane, LN6 7DL, Lincoln, Lincolnshire, United Kingdom.
ORCID-Profile: Riham A El-Shiekh
Zitieren
APA
Abdel-Sattar, E., Kutkat, O., El-Shiekh, R. A., El-Ashrey, M. K., & El Kerdawy, A. M. (2024). In Silico and In Vitro Screening of Some Pregnane Glycosides Isolated from Certain Caralluma Species as SARS‐COV‐2 Main Protease Inhibitors. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202301786
Vancouver
Abdel-Sattar E, Kutkat O, El-Shiekh RA, El-Ashrey MK, El Kerdawy AM. In Silico and In Vitro Screening of Some Pregnane Glycosides Isolated from Certain Caralluma Species as SARS‐COV‐2 Main Protease Inhibitors. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202301786
BibTeX
@article{AbdelSattar2024,
author = {Abdel-Sattar, Essam and Kutkat, Omnia and El-Shiekh, Riham A and El-Ashrey, Mohamed K and El Kerdawy, Ahmed M},
title = {In Silico and In Vitro Screening of Some Pregnane Glycosides Isolated from Certain Caralluma Species as SARS‐COV‐2 Main Protease Inhibitors},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202301786}
}
EUVIMED